Generate Biomedicines, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Generate Biomedicines, Inc. (GENB) had Common Stock, Capital Shares Reserved for Future Issuance of 31.61 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-06
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 31.61M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 31.69M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 93.26M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 31.61M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 31.69M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 93.26M shares 10-Q · filed 2026-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |